{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:01:44Z","timestamp":1792299704235,"version":"4.4.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Infect Dis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40506-020-00228-3","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T21:02:32Z","timestamp":1591650152000},"page":"227-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neurologic Complications of Acute HIV Infection"],"prefix":"10.1007","volume":"12","author":[{"given":"Kathryn B.","family":"Holroyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Vishnevetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maahika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Saylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"issue":"20","key":"228_CR1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra1011874","volume":"364","author":"MS Cohen","year":"2011","unstructured":"\u2022 Cohen MS, Shaw GM, AJ MM, Haynes BF. Acute HIV-1 Infection. N Engl J Med. 2011;364(20):1943\u201354 This provides a thorough review of clinical and pathophysiologic aspects of acute HIV infection.","journal-title":"N Engl J Med."},{"issue":"1","key":"228_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-199101000-00001","volume":"5","author":"B Tindall","year":"1991","unstructured":"Tindall B, Cooper DA. Primary HIV infection: host responses and intervention strategies. AIDS. 1991;5(1):1\u201314.","journal-title":"AIDS."},{"issue":"9","key":"228_CR3","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/429411","volume":"191","author":"MJ Wawer","year":"2005","unstructured":"Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191(9):1403\u20139.","journal-title":"J Infect Dis"},{"issue":"3","key":"228_CR4","doi-asserted-by":"crossref","first-page":"e1001801","DOI":"10.1371\/journal.pmed.1001801","volume":"12","author":"SE Bellan","year":"2015","unstructured":"Bellan SE, Dushoff J, Galvani AP, Meyers LA. Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts. PLoS Med. 2015;12(3):e1001801.","journal-title":"PLoS Med"},{"issue":"13","key":"228_CR5","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","volume":"17","author":"EW Fiebig","year":"2003","unstructured":"Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871\u20139.","journal-title":"AIDS."},{"issue":"12","key":"228_CR6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OLQ.0000000000000719","volume":"44","author":"CB Hurt","year":"2017","unstructured":"Hurt CB, Nelson JAE, Hightow-Weidman LB, Miller WC. Selecting an HIV test: a narrative review for clinicians and researchers. Sex Transm Dis. 2017;44(12):739\u201346.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"228_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciw666","volume":"64","author":"KP Delaney","year":"2017","unstructured":"Delaney KP, Hanson DL, Masciotra S, Ethridge SF, Wesolowski L, Owen SM. Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure. Clin Infect Dis. 2017;64(1):53\u20139.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"228_CR8","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1097\/QAD.0000000000000855","volume":"29","author":"JM Lewis","year":"2015","unstructured":"Lewis JM, Macpherson P, Adams ER, Ochodo E, Sands A, Taegtmeyer M. Field accuracy of fourth-generation rapid diagnostic tests for acute HIV-1: a systematic review. AIDS. 2015;29(18):2465\u201371.","journal-title":"AIDS."},{"key":"228_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcv.2017.06.006","volume":"94","author":"E Livant","year":"2017","unstructured":"Livant E, Heaps A, Kelly C, Maharaj R, Samsunder N, Nhlangulela L, et al. The fourth generation Alere(TM) HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples. J Clin Virol. 2017;94:15\u201321.","journal-title":"J Clin Virol"},{"issue":"8","key":"228_CR10","doi-asserted-by":"crossref","first-page":"e0183944","DOI":"10.1371\/journal.pone.0183944","volume":"12","author":"C Stafylis","year":"2017","unstructured":"Stafylis C, Klausner JD. Evaluation of two 4th generation point-of-care assays for the detection of human immunodeficiency virus infection. PLoS One. 2017;12(8):e0183944.","journal-title":"PLoS One"},{"issue":"12","key":"228_CR11","doi-asserted-by":"crossref","first-page":"e25419","DOI":"10.1002\/jia2.25419","volume":"22","author":"T Elliott","year":"2019","unstructured":"Elliott T, Sanders EJ, Doherty M, Ndung'u T, Cohen M, Patel P, et al. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review. J Int AIDS Soc. 2019;22(12):e25419.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"228_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","volume":"26","author":"F Hladik","year":"2007","unstructured":"Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007;26(2):257\u201370.","journal-title":"Immunity."},{"issue":"7037","key":"228_CR13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nature03513","volume":"434","author":"Q Li","year":"2005","unstructured":"Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 2005;434(7037):1148\u201352.","journal-title":"Nature."},{"issue":"1","key":"228_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65\u201370.","journal-title":"Arch Neurol"},{"issue":"9534","key":"228_CR15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","volume":"368","author":"V Simon","year":"2006","unstructured":"Simon V, Ho DD, Abdool KQ. HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368(9534):489\u2013504.","journal-title":"Lancet."},{"issue":"Suppl 1","key":"228_CR16","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1136\/jnnp.2003.034348","volume":"75","author":"H Manji","year":"2004","unstructured":"Manji H, Miller R. The neurology of HIV infection. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):i29\u201335.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"228_CR17","first-page":"186850","volume":"2012","author":"AC Silva","year":"2012","unstructured":"\u2022\u2022 Silva AC, Rodrigues BS, Micheletti AM, et al. Neuropathology of AIDS: an autopsy review of 284 cases from Brazil comparing the findings pre- and post-HAART (Highly Active Antiretroviral Therapy) and pre- and postmortem correlation. AIDS Res Treat. 2012;2012:186850 This paper evaluated 20 individuals with acute HIV infection, detecting CSF HIV DNA as early as 8 days after infection. Intrathecal inflammatory responses were also seen in some subjects.","journal-title":"AIDS Res Treat"},{"issue":"6075","key":"228_CR18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/322130a0","volume":"322","author":"AT Haase","year":"1986","unstructured":"Haase AT. Pathogenesis of lentivirus infections. Nature. 1986;322(6075):130\u20136.","journal-title":"Nature."},{"issue":"2","key":"228_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","volume":"206","author":"V Valcour","year":"2012","unstructured":"Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206(2):275\u201382.","journal-title":"J Infect Dis"},{"issue":"7","key":"228_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/343768","volume":"186","author":"JE Clements","year":"2002","unstructured":"Clements JE, Babas T, Mankowski JL, Suryanarayana K, Piatak M Jr, Tarwater PM, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis. 2002;186(7):905\u201313.","journal-title":"J Infect Dis"},{"issue":"9","key":"228_CR21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","volume":"42","author":"LE Davis","year":"1992","unstructured":"Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992;42(9):1736\u20139.","journal-title":"Neurology."},{"issue":"1","key":"228_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-5728(99)00150-2","volume":"102","author":"L Hagberg","year":"2000","unstructured":"Hagberg L, Fuchs D, Rosengren L, Gissl\u00e9n M. Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients. J Neuroimmunol. 2000;102(1):51\u20135.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"228_CR23","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/infdis\/jit088","volume":"207","author":"MJ Peluso","year":"2013","unstructured":"\u2022 Peluso MJ, Meyerhoff DJ, Price RW, et al. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis. 2013;207(11):1703\u201312 This paper describes cognitive changes as well as structural brain changes, including parenchymal loss and changes in white matter connectivity, in indviduals with early HIV infection.","journal-title":"J Infect Dis"},{"issue":"5","key":"228_CR24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jir387","volume":"204","author":"S Spudich","year":"2011","unstructured":"Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011;204(5):753\u201360.","journal-title":"J Infect Dis"},{"issue":"1","key":"228_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/acn3.136","volume":"2","author":"AB Ragin","year":"2015","unstructured":"Ragin AB, Wu Y, Gao Y, Keating S, du H, Sammet C, et al. Brain alterations within the first 100 days of HIV infection. Ann Clin Transl Neurol. 2015;2(1):12\u201321.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"228_CR26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/649899","volume":"201","author":"BM Ances","year":"2010","unstructured":"Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S, et al. HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis. 2010;201(3):336\u201340.","journal-title":"J Infect Dis"},{"issue":"6","key":"228_CR27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/135965350501000607","volume":"10","author":"A Mellgren","year":"2005","unstructured":"Mellgren A, Antinori A, Cinque P, et al. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Antivir Ther. 2005;10(6):701\u20137.","journal-title":"Antivir Ther"},{"issue":"4","key":"228_CR28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2055-6640(20)30926-2","volume":"1","author":"A Gega","year":"2015","unstructured":"Gega A, Kozal MJ, Chiarella J, Lee E, Peterson J, Hecht FM, et al. Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection. J Virus Erad. 2015;1(4):264\u20138.","journal-title":"J Virus Erad"},{"issue":"3","key":"228_CR29","doi-asserted-by":"crossref","first-page":"e1004720","DOI":"10.1371\/journal.ppat.1004720","volume":"11","author":"CB Sturdevant","year":"2015","unstructured":"Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog. 2015;11(3):e1004720.","journal-title":"PLoS Pathog"},{"issue":"5","key":"228_CR30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","volume":"50","author":"A Canestri","year":"2010","unstructured":"Canestri A, Lescure FX, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis. 2010;50(5):773\u20138.","journal-title":"Clin Infect Dis"},{"issue":"14","key":"228_CR31","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","volume":"26","author":"MJ Peluso","year":"2012","unstructured":"\u2022\u2022 Peluso MJ, Ferretti F, Peterson J, et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012;26(14):1765\u201374 This study demonstrated that early initiation of ART led to significantly less molecular diversity of CNS HIV and lower levels of inflammation within the CNS but did not prevent CNS compartmentalization.","journal-title":"AIDS"},{"issue":"3","key":"228_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","volume":"25","author":"M Smurzynski","year":"2011","unstructured":"Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, et al. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 2011;25(3):357\u201365.","journal-title":"AIDS."},{"issue":"1","key":"228_CR33","doi-asserted-by":"crossref","first-page":"e1006112","DOI":"10.1371\/journal.ppat.1006112","volume":"13","author":"MF Oliveira","year":"2017","unstructured":"Oliveira MF, Chaillon A, Nakazawa M, Vargas M, Letendre SL, Strain MC, et al. Early antiretroviral therapy is associated with lower HIV DNA molecular diversity and lower inflammation in cerebrospinal fluid but does not prevent the establishment of compartmentalized HIV DNA populations. PLoS Pathog. 2017;13(1):e1006112.","journal-title":"PLoS Pathog"},{"issue":"12","key":"228_CR34","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/infdis\/jiw454","volume":"214","author":"A Ed\u00e9n","year":"2016","unstructured":"Ed\u00e9n A, Nilsson S, Hagberg L, Fuchs D, Zetterberg H, Svennerholm B, et al. Asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: a longitudinal study. J Infect Dis. 2016;214(12):1822\u20135.","journal-title":"J Infect Dis"},{"issue":"1","key":"228_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/infdis\/jix553","volume":"217","author":"RA van Zoest","year":"2017","unstructured":"van Zoest RA, Underwood J, De Francesco D, et al. Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers. J Infect Dis. 2017;217(1):69\u201381.","journal-title":"J Infect Dis"},{"issue":"4","key":"228_CR36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/QAI.0000000000001687","volume":"78","author":"J Underwood","year":"2018","unstructured":"Underwood J, Cole JH, Leech R, Sharp DJ, Winston A. Group C. multivariate pattern analysis of volumetric neuroimaging data and its relationship with cognitive function in treated HIV disease. J Acquir Immune Defic Syndr. 2018;78(4):429\u201336.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"228_CR37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/cid\/ciy267","volume":"67","author":"SS Mukerji","year":"2018","unstructured":"Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, et al. Impact of antiretroviral regimens on cerebrospinal fluid viral escape in a prospective multicohort study of antiretroviral therapy-experienced human immunodeficiency Virus-1-infected adults in the United States. Clin Infect Dis. 2018;67(8):1182\u201390.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"228_CR38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000001362","volume":"75","author":"SS Mukerji","year":"2017","unstructured":"Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, et al. Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults. J Acquir Immune Defic Syndr. 2017;75(2):246\u201355.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"228_CR39","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1097\/QAD.0000000000002326","volume":"33 Suppl 2","author":"S Spudich","year":"2019","unstructured":"\u2022\u2022 Spudich S, Peterson J, Fuchs D, Price RW, Gisslen M. Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence. AIDS. 2019;33 Suppl 2:S135\u201344 This paper prospectively evaluated neurologic manifestations of acute HIV in 139 participants, finding frequent mild neurologic changes including cognitive symptoms, motor findings, and neuropathy.","journal-title":"AIDS"},{"issue":"10","key":"228_CR40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/brainsci8100190","volume":"8","author":"DA Collier","year":"2018","unstructured":"Collier DA, Haddow L, Brijkumar J, Moosa MS, Benjamin L, Gupta RK. HIV Cerebrospinal fluid escape and neurocognitive pathology in the era of combined antiretroviral therapy: what lies beneath the tip of the iceberg in Sub-Saharan Africa? Brain Sci. 2018;8(10):190.","journal-title":"Brain Sci"},{"issue":"2","key":"228_CR41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.0000000000002837","volume":"87","author":"J Hellmuth","year":"2016","unstructured":"Hellmuth J, Fletcher JL, Valcour V, Kroon E, Ananworanich J, Intasan J, et al. Neurologic signs and symptoms frequently manifest in acute HIV infection. Neurology. 2016;87(2):148\u201354.","journal-title":"Neurology."},{"issue":"6","key":"228_CR42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/313810","volume":"30","author":"G Tambussi","year":"2000","unstructured":"Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, et al. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis. 2000;30(6):962\u20135.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"228_CR43","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/QAI.0000000000000746","volume":"70","author":"I Kore","year":"2015","unstructured":"Kore I, Ananworanich J, Valcour V, Fletcher JL, Chalermchai T, Paul R, et al. Neuropsychological impairment in acute HIV and the effect of immediate antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;70(4):393\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"228_CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1471-2334-14-149","volume":"14","author":"P Andrade","year":"2014","unstructured":"Andrade P, Figueiredo C, Carvalho C, Santos L, Sarmento A. Transverse myelitis and acute HIV infection: a case report. BMC Infect Dis. 2014;14:149.","journal-title":"BMC Infect Dis"},{"issue":"6565","key":"228_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/bmj.294.6565.143","volume":"294","author":"DW Denning","year":"1987","unstructured":"Denning DW, Anderson J, Rudge P, Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J (Clin Res Ed). 1987;294(6565):143\u20134.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"15","key":"228_CR46","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2169\/internalmedicine.50.5186","volume":"50","author":"Y Hamada","year":"2011","unstructured":"Hamada Y, Watanabe K, Aoki T, Arai N, Honda M, Kikuchi Y, et al. Primary HIV infection with acute transverse myelitis. Intern Med. 2011;50(15):1615\u20137.","journal-title":"Intern Med"},{"issue":"3","key":"228_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nrl.2015.06.006","volume":"32","author":"F P\u00e9rez-Bartolom\u00e9","year":"2017","unstructured":"P\u00e9rez-Bartolom\u00e9 F, Santos-Bueso E, \u00c1valos-Franco N, Porta-Etessam J. Unilateral retrobulbar optic neuropathy as the initial manifestation of human immunodeficiency virus infection. Neurologia. 2017;32(3):199\u2013201.","journal-title":"Neurologia."},{"issue":"3","key":"228_CR48","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1212\/CPJ.0000000000000583","volume":"9","author":"E Fortin","year":"2019","unstructured":"Fortin E, Heller HM, Lyons J, Prasad S. Bilateral optic neuritis from acute HIV infection. Neurol Clin Pract. 2019;9(3):e19\u201321.","journal-title":"Neurol Clin Pract"},{"issue":"6","key":"228_CR49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1034\/j.1600-0420.1998.760623.x","volume":"76","author":"M Larsen","year":"1998","unstructured":"Larsen M, Toft PB, Bernhard P, Herning M. Bilateral optic neuritis in acute human immunodeficiency virus infection. Acta Ophthalmol Scand. 1998;76(6):737\u20138.","journal-title":"Acta Ophthalmol Scand"},{"issue":"10","key":"228_CR50","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0956462417693734","volume":"28","author":"EJ Lee","year":"2017","unstructured":"Lee EJ, Kim YH, Lee JY, Sunwoo JS, Park SY, Kim TH. Acute HIV-1 infection presenting with fulminant encephalopathy. Int J STD AIDS. 2017;28(10):1041\u20134.","journal-title":"Int J STD AIDS"},{"issue":"8","key":"228_CR51","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.57.8.1493","volume":"57","author":"P Narciso","year":"2001","unstructured":"Narciso P, Galgani S, Del Grosso B, et al. Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology. 2001;57(8):1493\u20136.","journal-title":"Neurology."},{"issue":"1","key":"228_CR52","first-page":"160","volume":"23","author":"A Naidoo","year":"2017","unstructured":"Naidoo A, Paruk H, Bhagwan B, Moodley A. Atypical presentations of acute disseminated encephalomyelitis (ADEM) in HIV infection. J Neuro-Oncol. 2017;23(1):160\u201370.","journal-title":"J Neuro-Oncol"},{"issue":"8","key":"228_CR53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/339756","volume":"34","author":"S Abad","year":"2002","unstructured":"Abad S, Touze E, Blanche P, Sicard D, Salmon-Ceron D, Mas JL, et al. Shoulder girdle syndrome revealing primary HIV infection. Clin Infect Dis. 2002;34(8):1162\u20133.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"228_CR54","first-page":"11","volume":"42","author":"DW Denning","year":"1988","unstructured":"Denning DW. The neurological features of acute HIV infection. Biomed Pharmacother. 1988;42(1):11\u20134.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"228_CR55","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/511876","volume":"44","author":"P Serrano","year":"2007","unstructured":"Serrano P, Hern\u00e1ndez N, Arroyo JA, de Llobet JM, Domingo P. Bilateral Bell palsy and acute HIV type 1 infection: report of 2 cases and review. Clin Infect Dis. 2007;44(6):e57\u201361.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"228_CR56","first-page":"604","volume":"159","author":"CG Krasner","year":"1993","unstructured":"Krasner CG, Cohen SH. Bilateral Bell\u2019s palsy and aseptic meningitis in a patient with acute human immunodeficiency virus seroconversion. West J Med. 1993;159(5):604\u20135.","journal-title":"West J Med"},{"key":"228_CR57","first-page":"267405","volume":"2012","author":"LM Ruiz","year":"2012","unstructured":"Ruiz LM, Kirmani B. Presentation of bilateral peripheral seventh cranial nerve palsy in an HIV patient. Case Rep Neurol Med. 2012;2012:267405.","journal-title":"Case Rep Neurol Med"},{"issue":"6","key":"228_CR58","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/00365548609021668","volume":"18","author":"L Hagberg","year":"1986","unstructured":"Hagberg L, Malmvall BE, Svennerholm L, Alestig K, Norkrans G. Guillain-Barr\u00e9 syndrome as an early manifestation of HIV central nervous system infection. Scand J Infect Dis. 1986;18(6):591\u20132.","journal-title":"Scand J Infect Dis"},{"issue":"8","key":"228_CR59","doi-asserted-by":"crossref","first-page":"e005107","DOI":"10.1099\/jmmcr.0.005107","volume":"4","author":"SJ Shepherd","year":"2017","unstructured":"Shepherd SJ, Black H, Thomson EC, Gunson RN. HIV positive patient with GBS-like syndrome. JMM Case Rep. 2017;4(8):e005107.","journal-title":"JMM Case Rep"},{"key":"228_CR60","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1752-1947-2-370","volume":"2","author":"DJ Sloan","year":"2008","unstructured":"Sloan DJ, Nicolson A, Miller AR, Beeching NJ, Beadsworth MB. Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report. J Med Case Rep. 2008;2:370.","journal-title":"J Med Case Rep"},{"issue":"2","key":"228_CR61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3760\/cma.j.issn.0366-6999.20131338","volume":"127","author":"AN Varshney","year":"2014","unstructured":"Varshney AN, Anand R, Bhattacharjee A, Prasad P, Kumar N, Singh NK. HIV seroconversion manifesting as Guillian-Barre syndrome. Chin Med J. 2014;127(2):396.","journal-title":"Chin Med J"},{"issue":"4","key":"228_CR62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0923-2516(90)90043-I","volume":"141","author":"P Paton","year":"1990","unstructured":"Paton P, Poly H, Gonnaud PM, Tardy JC, Fontana J, Kindbeiter K, et al. Acute meningoradiculitis concomitant with seroconversion to human immunodeficiency virus type 1. Res Virol. 1990;141(4):427\u201333.","journal-title":"Res Virol"},{"issue":"6","key":"228_CR63","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-107-6-849","volume":"107","author":"LH Calabrese","year":"1987","unstructured":"Calabrese LH, Proffitt MR, Levin KH, Yen-Lieberman B, Starkey C. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann Intern Med. 1987;107(6):849\u201351.","journal-title":"Ann Intern Med"},{"issue":"1","key":"228_CR64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroimage.2009.01.054","volume":"46","author":"MM Mielke","year":"2009","unstructured":"Mielke MM, Kozauer NA, Chan KC, George M, Toroney J, Zerrate M, et al. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer\u2019s disease. Neuroimage. 2009;46(1):47\u201355.","journal-title":"Neuroimage."},{"issue":"2","key":"228_CR65","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.intimp.2015.09.023","volume":"29","author":"EC Rosca","year":"2015","unstructured":"Rosca EC, Rosca O, Simu M. Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barr\u00e9 syndrome. Int Immunopharmacol. 2015;29(2):964\u20135.","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"228_CR66","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75(23):2087\u201396.","journal-title":"Neurology."},{"issue":"2","key":"228_CR67","first-page":"176","volume":"17","author":"LA Cysique","year":"2011","unstructured":"Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. J Neuro-Oncol. 2011;17(2):176\u201383.","journal-title":"J Neuro-Oncol"},{"key":"228_CR68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12981-016-0111-1","volume":"13","author":"SP Eholi\u00e9","year":"2016","unstructured":"Eholi\u00e9 SP, Badje A, Kouame GM, N\u2019takpe JB, Moh R, Danel C, et al. Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question. AIDS Res Ther. 2016;13:27.","journal-title":"AIDS Res Ther"},{"key":"228_CR69","doi-asserted-by":"crossref","unstructured":"Gao C, Meing J, Xiao X, Wang M, Barterly Williams A, Wang H. Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis. In. In Press ed. International Journal of Nursing Sciences 2020.","DOI":"10.1016\/j.ijnss.2020.03.007"},{"key":"228_CR70","unstructured":"Robertson K, Lama JR, Pilcher CD, et al. Can we afford to wait? ART and the CNS. In. Conference on retroviruses and autoimmune infections 2017."},{"issue":"1","key":"228_CR71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiw505","volume":"215","author":"AM Anderson","year":"2017","unstructured":"Anderson AM, Mu\u00f1oz-Moreno JA, McClernon DR, Ellis RJ, Cookson D, Clifford DB, et al. Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. J Infect Dis. 2017;215(1):105\u201313.","journal-title":"J Infect Dis"},{"issue":"5","key":"228_CR72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/QAI.0b013e31827f1bdb","volume":"62","author":"BB Gelman","year":"2013","unstructured":"Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr. 2013;62(5):487\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"228_CR73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S2055-6640(20)30489-1","volume":"1","author":"J Hellmuth","year":"2015","unstructured":"Hellmuth J, Valcour V, Spudich S. CNS reservoirs for HIV: implications for eradication. J Virus Erad. 2015;1(2):67\u201371.","journal-title":"J Virus Erad"},{"issue":"3","key":"228_CR74","doi-asserted-by":"crossref","first-page":"e33948","DOI":"10.1371\/journal.pone.0033948","volume":"7","author":"J Ananworanich","year":"2012","unstructured":"Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One. 2012;7(3):e33948.","journal-title":"PLoS One"},{"issue":"7","key":"228_CR75","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/infdis\/jix662","volume":"217","author":"PD Burbelo","year":"2018","unstructured":"\u2022\u2022 Burbelo PD, Price RW, Hagberg L, et al. Anti-human immunodeficiency virus antibodies in the cerebrospinal fluid: evidence of early treatment impact on central nervous system reservoir? J Infect Dis. 2018;217(7):1024\u201332 This study followed 8 patients who were treated with ART in the earliest phase of acute HIV (Fiebig I). Viral rebound was seen in all patients despite undetectable HIV-1 RNA in reservoirs such as CSF, gut, or lymph nodes at time of diagnosis. This highlights the difficulty in eradicating HIV even with very early treatment and highlights the need for a cure.","journal-title":"J Infect Dis"},{"issue":"11","key":"228_CR76","doi-asserted-by":"crossref","first-page":"e1002417","DOI":"10.1371\/journal.pmed.1002417","volume":"14","author":"TJ Henrich","year":"2017","unstructured":"Henrich TJ, Hatano H, Bacon O, et al. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study. PLoS Med. 2017;14(11):e1002417.","journal-title":"PLoS Med"},{"issue":"7","key":"228_CR77","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","volume":"24","author":"DJ Colby","year":"2018","unstructured":"Colby DJ, Trautmann L, Pinyakorn S, et al. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat Med. 2018;24(7):923\u20136.","journal-title":"Nat Med"},{"issue":"1","key":"228_CR78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s13365-013-0225-3","volume":"20","author":"DB Smith","year":"2014","unstructured":"Smith DB, Simmonds P, Bell JE. Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users. J Neurovirol. 2014;20(1):28\u201338.","journal-title":"J Neurovirol"},{"issue":"3","key":"228_CR79","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","volume":"21","author":"SB Joseph","year":"2015","unstructured":"\u2022 Joseph SB, Arrildt KT, Sturdevant CB, Swanstrom R. HIV-1 target cells in the CNS. J Neurovirol. 2015;21(3):276\u201389 This review discusses in detail the pathophysiology behind HIV penetration into the CNS and barriers to development of cure strategies on both a molecular and a clinical level.","journal-title":"J Neurovirol"},{"issue":"1","key":"228_CR80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/653213","volume":"202","author":"MC Zink","year":"2010","unstructured":"Zink MC, Brice AK, Kelly KM, et al. Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis. 2010;202(1):161\u201370.","journal-title":"J Infect Dis"},{"key":"228_CR81","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ebiom.2019.06.020","volume":"45","author":"MM Elsheikh","year":"2019","unstructured":"Elsheikh MM, Tang Y, Li D, Jiang G. Deep latency: a new insight into a functional HIV cure. EBioMedicine. 2019;45:624\u20139.","journal-title":"EBioMedicine."},{"issue":"10","key":"228_CR82","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1258\/ijsa.2011.010507","volume":"22","author":"R Bingham","year":"2011","unstructured":"Bingham R, Ahmed N, Rangi P, Johnson M, Tyrer M, Green J. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS. 2011;22(10):608\u20139.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"228_CR83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/cid\/cit175","volume":"57","author":"FX Lescure","year":"2013","unstructured":"Lescure FX, Moulignier A, Savatovsky J, et al. CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity. Clin Infect Dis. 2013;57(1):101\u20138.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"228_CR84","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G H\u00fctter","year":"2009","unstructured":"H\u00fctter G, Nowak D, Mossner M, et al. Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N Engl J Med. 2009;360(7):692\u20138.","journal-title":"N Engl J Med"},{"issue":"7751","key":"228_CR85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","volume":"568","author":"RK Gupta","year":"2019","unstructured":"Gupta RK, Abdul-Jawad S, McCoy LE, et al. HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation. Nature. 2019;568(7751):244\u20138.","journal-title":"Nature."},{"issue":"9","key":"228_CR86","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/MCB.22.9.2965-2973.2002","volume":"22","author":"G He","year":"2002","unstructured":"He G, Margolis DM. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol. 2002;22(9):2965\u201373.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"228_CR87","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1172\/JCI98071","volume":"128","author":"G Jiang","year":"2018","unstructured":"Jiang G, Nguyen D, Archin NM, et al. HIV latency is reversed by ACSS2-driven histone crotonylation. J Clin Invest. 2018;128(3):1190\u20138.","journal-title":"J Clin Invest"},{"issue":"4","key":"228_CR88","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/v6041715","volume":"6","author":"A Battistini","year":"2014","unstructured":"Battistini A, Sgarbanti M. HIV-1 latency: an update of molecular mechanisms and therapeutic strategies. Viruses. 2014;6(4):1715\u201358.","journal-title":"Viruses."},{"key":"228_CR89","doi-asserted-by":"crossref","first-page":"39032","DOI":"10.1038\/srep39032","volume":"6","author":"J Brogdon","year":"2016","unstructured":"Brogdon J, Ziani W, Wang X, Veazey RS, Xu H. In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation. Sci Rep. 2016;6:39032.","journal-title":"Sci Rep"},{"key":"228_CR90","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fmicb.2017.01035","volume":"8","author":"H Huang","year":"2017","unstructured":"Huang H, Liu S, Jean M, et al. A novel bromodomain inhibitor reverses HIV-1 latency through specific binding with BRD4 to promote Tat and P-TEFb association. Front Microbiol. 2017;8:1035.","journal-title":"Front Microbiol"},{"issue":"2","key":"228_CR91","doi-asserted-by":"crossref","first-page":"e0211746","DOI":"10.1371\/journal.pone.0211746","volume":"14","author":"M Bobardt","year":"2019","unstructured":"Bobardt M, Kuo J, Chatterji U, et al. The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate. PLoS One. 2019;14(2):e0211746.","journal-title":"PLoS One"},{"issue":"7408","key":"228_CR92","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","volume":"487","author":"NM Archin","year":"2012","unstructured":"Archin NM, Liberty AL, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487(7408):482\u20135.","journal-title":"Nature."},{"issue":"10","key":"228_CR93","doi-asserted-by":"crossref","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","volume":"10","author":"JH Elliott","year":"2014","unstructured":"Elliott JH, Wightman F, Solomon A, et al. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. PLoS Pathog. 2014;10(10):e1004473.","journal-title":"PLoS Pathog"},{"issue":"15","key":"228_CR94","doi-asserted-by":"crossref","first-page":"E1528","DOI":"10.1073\/pnas.1320178111","volume":"111","author":"I Anderson","year":"2014","unstructured":"Anderson I, Low JS, Weston S, et al. Heat shock protein 90 controls HIV-1 reactivation from latency. Proc Natl Acad Sci U S A. 2014;111(15):E1528\u201337.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"228_CR95","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2017.09.080","volume":"21","author":"CF Kessing","year":"2017","unstructured":"Kessing CF, Nixon CC, Li C, et al. In vivo suppression of HIV rebound by didehydro-cortistatin A, a \u201cblock-and-lock\u201d strategy for HIV-1 treatment. Cell Rep. 2017;21(3):600\u201311.","journal-title":"Cell Rep"}],"container-title":["Current Treatment Options in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40506-020-00228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40506-020-00228-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40506-020-00228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T05:50:19Z","timestamp":1723009819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40506-020-00228-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1007\/s40506-020-00228-3","relation":{},"ISSN":["1534-6250"],"issn-type":[{"value":"1534-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"8 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Deanna Saylor declares that she has no conflict of interest. Kathryn B. Holroyd declares that she has no conflict of interest. Anastasia Vishnevetsky declares that she has no conflict of interest. Maahika Srinivasan declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}},{"value":"No ethics board approval was required for this narrative review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}